(Q30640288)

25 June 2017

Longitudinal data analysis: an application to construction of a natural history profile of Duchenne muscular dystrophy (English)

1 reference

Duchenne muscular dystrophy

25 June 2017

0 references

1 reference

Hyde SA

1

1 reference

25 June 2017

Steffensen BF

2

1 reference

25 June 2017

Fløytrup I

3

1 reference

25 June 2017

Glent S

4

1 reference

25 June 2017

Kroksmark AK

5

1 reference

25 June 2017

Salling B

6

1 reference

25 June 2017

Werlauff U

7

1 reference

25 June 2017

Erlandsen M

8

1 reference

25 June 2017

1 March 2001

1 reference

25 June 2017

Neuromuscular Disorders

1 reference

25 June 2017

11

1 reference

25 June 2017

2

1 reference

25 June 2017

165-170

1 reference

Clinical trial in Duchenne dystrophy. I. The design of the protocol

25 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Clinical investigation in duchenne dystrophy: 2. Determination of the ?power? of therapeutic trials based on the natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Profiles of neuromuscular diseases. Design of the protocol.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Evaluation of a program for long-term treatment of Duchenne muscular dystrophy. Experience at the University Hospitals of Cleveland

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Therapeutic trial of isaxonine in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Subcellular fractionation of dystrophin to the triads of skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Steroids in Duchenne muscular dystrophy; pilot study of a new low-dosage schedule

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Isokinetic muscle testing (IMT) in neuromuscular diseases. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

General methods for analysing repeated measures

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

A randomized comparative study of two methods for controlling Tendo Achilles contracture in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

Manual muscle testing

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2800%2900175-9

7 January 2021

10.1016/S0960-8966(00)00175-9

Identifiers

DOI

1 reference

25 June 2017

1 reference